Quarterly report pursuant to Section 13 or 15(d)

Organization and Description of The Business

v3.7.0.1
Organization and Description of The Business
3 Months Ended
Jun. 30, 2017
Notes  
Organization and Description of The Business

NOTE 1 - ORGANIZATION AND DESCRIPTION OF THE BUSINESS

 

Cantabio Pharmaceuticals Inc. (the “Company” or “Cantabio”) is a preclinical stage biotechnology company focusing on commercializing novel therapies and the intellectual property generated from research and development activities for Parkinson’s disease (PD) and Alzheimer’s disease (AD).  The Company’s strategy involves integration of therapeutic focus, the targeting of family biophysics, drug discovery technology and expertise into an innovative drug discovery approach, which synergizes to identify and develop small molecule pharmacological chaperones for clinical trials. In addition, the Company’s research efforts concentrate on the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins with display loss of function during disease conditions.